New chemo spray shows promise for Hard-to-Treat abdominal cancers
NCT ID NCT06367270
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method called PIPAC, which sprays chemotherapy directly into the abdomen as a fine mist. It is for people with stomach, pancreas, or colorectal cancer that has spread to the lining of the abdomen. The goal is to see if this approach can control the cancer and improve quality of life. About 60 adults will receive three treatments along with standard chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Queen Mary Hospital
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
- New radiation technique targets stomach and ovarian cancer spread without surgery
- New chemo spray aims to ease suffering from abdominal cancer spread
- Could chemo around surgery beat cancer spread in the belly?
- PET scans may improve chemo decisions for abdominal cancer patients
- Fish oil drink before surgery may cut complications, tiny study hints